HKAPI

To drive the expedient access of innovative healthcare solutions for the people of Hong Kong and Macau with high ethical standards. Formed in 1968, The Hong Kong Association of the Pharmaceutical Industry has 33 full members, including the world's top 20 companies engaged in the research and development of pharmaceuticals. Our member companies provide over 70 percent of the prescription medicines in Hong Kong. Updating members with important information in the local pharmaceutical market, the Association aims to improve the overall well-being of Hong Kong people by making recommendations on healthcare policies, as well as the relationship among our member companies, the government and the community. The Association has actively participated in the events of the local health community and regularly presented its views to the public on different healthcare issues such as Voluntary Health Insurance Scheme, Pharmacy and Poisons (Amendment) Ordinance 2015 and various pharmaceutical regulations.

“One Platform” of Patient Support Programs (PSPs)
Patient Support Programs or Patient Assistance Programs (PSP) in this platform refer to programs initiated primarily by pharmaceutical companies with the aim to help patients to access to innovative medicines through various mechanisms, for example, providing eligible patients with price discount, refund or with free products etc
Centralized platform of PSPs established by the Hong Kong Association of the Pharmaceutical Industry (HKAPI)
Consolidate PSPs from key pharmaceutical companies in Hong Kong
Fast access to most updated information of PSPs
Easy and systematic way to get all details of PSPs anytime and anywhere